AnaptysBio, Inc (ANAB) stock
ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
$49.24+2.63 (+5.64%)
Close on Oct 19, 2026Market cap $2.28BP/E –Yield –
AnaptysBio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
AnaptysBio's price to sales ratio was 6.2× on Oct 19, 2026, against 5.5× a year earlier. Over the last 5 years it ranged from 3.1× to 130.5×, with a median of 8.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 6.2× | +0.9 |
| 2025 | Dec 31, 2025 | 5.3× | +0.6 |
| 2024 | Dec 31, 2024 | 4.7× | −20.7 |
| 2023 | Dec 29, 2023 | 25.4× | −105.1 |
| 2022 | Dec 30, 2022 | 130.5× | +125.3 |
| 2021 | Dec 31, 2021 | 5.2× | −16.6 |
| 2020 | Dec 31, 2020 | 21.8× | −36.9 |
| 2019 | Dec 31, 2019 | 58.7× | −83.5 |
| 2018 | Dec 31, 2018 | 142.2× | +1.1 |
| 2017 | Dec 29, 2017 | 141.1× | – |
See a number that looks wrong?